Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
about
A role for methyl-CpG binding domain protein 2 in the modulation of the estrogen response of pS2/TFF1 geneSequence-specific transcriptional repression by an MBD2-interacting zinc finger protein MIZFThe thymine DNA glycosylase MBD4 represses transcription and is associated with methylated p16(INK4a) and hMLH1 genesSpecific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus.Isolation and characterization of a novel DNA methyltransferase complex linking DNMT3B with components of the mitotic chromosome condensation machineryDNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancersEpigenetic inactivation of CHFR in human tumorsEmerging Molecular and Biological Functions of MBD2, a Reader of DNA MethylationATP-dependent chromatin remodeling complexes as novel targets for cancer therapySolution structure and dynamic analysis of chicken MBD2 methyl binding domain bound to a target-methylated DNA sequenceSite-selective in vivo targeting of cytosine-5 DNA methylation by zinc-finger proteinsMethylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architectureInteraction between the 2'-5' oligoadenylate synthetase-like protein p59 OASL and the transcriptional repressor methyl CpG-binding protein 1MeCP2: the chromatin connection and beyondLong term transcriptional reactivation of epigenetically silenced genes in colorectal cancer cells requires DNA hypomethylation and histone acetylationMethyl binding domain protein 2 mediates gamma-globin gene silencing in adult human betaYAC transgenic miceThe affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties.CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.Plasma cell leukemia.Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation.Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcriptionMethyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer.Cancer biology and NuRD: a multifaceted chromatin remodelling complexEpigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines.Constant p53 pathway inactivation in a large series of soft tissue sarcomas with complex genetics.Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer.Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation.Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.Transcriptional regulation of hTREX84 in human cancer cells.Synergistic effects of combined DNA methyltransferase inhibition and MBD2 depletion on breast cancer cells; MBD2 depletion blocks 5-aza-2'-deoxycytidine-triggered invasivenessMethyl CpG-binding proteins and transcriptional repression.Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2).Polymorphisms in promoter sequences of MDM2, p53, and p16 genes in normal Japanese individuals.Beyond Watson and Crick: DNA methylation and molecular enzymology of DNA methyltransferases.MeCP2 and other methyl-CpG binding proteins.Aberrant DNA hypermethylation patterns lead to transcriptional silencing of tumor suppressor genes in UVB-exposed skin and UVB-induced skin tumors of mice.Methyl-CpG binding proteins and cancer: are MeCpGs more important than MBDs?Reactivating the expression of methylation silenced genes in human cancer.Chromatin modification, leukaemia and implications for therapy.
P2860
Q21142628-99F185D0-9AB8-4C12-82D4-E4B714A8F196Q24306708-77702343-C6A2-44C3-B812-7C5042A55728Q24529077-4239EA1E-CA80-44BC-B394-8B61E8121280Q24533103-9C6B3078-A3EC-4B31-B6BE-5EC1062521E8Q24562316-F3E18532-F1FA-44FD-9054-878758FE88F2Q24642645-D2FBCC89-A365-4B60-B34B-2798BF390936Q24670147-74DA6111-A2D7-43B9-9B9F-7A65CFBD04A4Q26745958-B25721A9-57AF-410A-8E11-D8E331291A62Q26849467-D7047ABC-B602-40CF-9684-AD61FFC58EFBQ27667623-822157DF-F1BA-4326-845B-B533849A7CCCQ28182259-E1916EE7-F359-459D-A1A3-1F3CC6E71DE7Q28208766-DC198526-1261-470C-88B8-E3058CFE3BB0Q28239188-00E4D496-B6F8-44EA-B838-7E8A8832EAD8Q28256925-611B0072-C805-4B93-921A-5009B29EA5BCQ28476454-C3BAC136-F799-43BB-9B07-EF26FFF9CA7CQ28590402-89BB9D09-3198-4ACA-A21F-C1854C728A0DQ33186320-AE5EFFC2-C691-4CBF-8333-57F7BD3C45CBQ33337445-8A5F1254-AA14-4551-B945-7EB0A20C6D94Q33393995-0F9CA1B1-E1D0-46FA-8530-4D4A24DEB7CEQ33529488-6386B549-0373-4A03-AC75-8169E21ABDA8Q33988438-F6418D59-C449-44C4-87B2-6A5791D8FF16Q34042749-EDC702E4-2AE9-436D-A6C5-D89E5E18DA36Q34053125-4228C61E-1354-4E3A-A216-B53B037FD859Q34148512-57F8B76F-A074-422C-8490-919710406AEDQ34160419-E8AED85E-BCE4-48FA-A6B3-A42451852502Q34162527-A6BACC82-03D3-46C3-ADD8-CD2D9B4F2D9CQ34280188-98B795F0-F3F8-4469-ABB7-9DA84CD3594CQ34324051-15556560-7CAE-4A6E-B00D-0FD3D6CEE7E1Q34329052-EA77447C-170E-4F6F-A64A-EE61C527C05CQ34405377-D0D1263D-6410-45B7-96E0-EAA846511A7BQ34434924-39F935F1-8188-47F2-B9FE-7B40B0C27A43Q34464674-F8AB2DD0-B5E9-4673-83B0-E690D1DF7B16Q34550062-AE5EDAEE-C644-4C00-9E92-5A1E73192438Q34562906-C52D8C9D-121D-4D37-B084-A2DC6CABF4C9Q34587622-0C7CE9BA-01D3-4BB2-8096-530CAF55D40AQ34733505-B9358692-6394-49B5-B984-33805CF2BF60Q34734084-463C252E-D649-4CB7-9EAB-FAC8C15EE02AQ34770530-80240F62-28ED-4212-8AB3-E18EAA6687AFQ34770617-68777939-0B8B-48AB-A9E7-7274C036C827Q34786248-295743A9-5B92-4AB3-8938-0FFB23D8E059
P2860
Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Selective association of the m ...... /p16 locus in human neoplasia.
@ast
Selective association of the m ...... /p16 locus in human neoplasia.
@en
type
label
Selective association of the m ...... /p16 locus in human neoplasia.
@ast
Selective association of the m ...... /p16 locus in human neoplasia.
@en
prefLabel
Selective association of the m ...... /p16 locus in human neoplasia.
@ast
Selective association of the m ...... /p16 locus in human neoplasia.
@en
P2860
P356
P1476
Selective association of the m ...... /p16 locus in human neoplasia.
@en
P2093
A P Wolffe
F Magdinier
P2860
P304
P356
10.1073/PNAS.101617298
P407
P577
2001-04-17T00:00:00Z